BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16586043)

  • 1. Recurrent congenital heart block in neonatal lupus.
    Escobar MC; Gómez-Puerta JA; Albert D; Ferrer Q; Girona J
    Clin Rheumatol; 2007 Jul; 26(7):1161-3. PubMed ID: 16586043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal lupus: bedside to bench and back.
    Buyon JP
    Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies.
    Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA
    Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
    Friedman DM; Rupel A; Glickstein J; Buyon JP
    Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block.
    Ivanchenko M; Thorlacius GE; Hedlund M; Ottosson V; Meneghel L; Björkander S; Ossoinak A; Tingström J; Bremme K; Sverremark-Ekström E; Gemzell-Danielsson K; Sonesson SE; Chemin K; Wahren-Herlenius M
    Ann Rheum Dis; 2021 Feb; 80(2):194-202. PubMed ID: 33004330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New findings in neonatal lupus syndrome.
    Lee LA; Weston WL
    Am J Dis Child; 1984 Mar; 138(3):233-6. PubMed ID: 6608264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in Sjögren's Syndrome.
    Fayyaz A; Kurien BT; Scofield RH
    Rheum Dis Clin North Am; 2016 Aug; 42(3):419-34. PubMed ID: 27431345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.
    Gleicher N; Elkayam U
    Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of recurrent congenital heart block in a SSA/SSB positive mother using high dose maternal IVIG from 16-week gestation.
    Sterling RA; Carlin A
    Prenat Diagn; 2015 Nov; 35(11):1148-50. PubMed ID: 26179183
    [No Abstract]   [Full Text] [Related]  

  • 15. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
    Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune-mediated congenital heart block.
    Wainwright B; Bhan R; Trad C; Cohen R; Saxena A; Buyon J; Izmirly P
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():41-51. PubMed ID: 31685414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neonatal antinuclear antibodies and the lupus syndrome].
    Pennec Y; Colin A; Youinou P; Alix D
    Arch Fr Pediatr; 1985; 42(7):517-9. PubMed ID: 3878694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ro (SS-A) protein and its antibodies].
    Meyer O
    Presse Med; 1989 May; 18(19):960-2. PubMed ID: 2525719
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center.
    Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G
    Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.